CROs offering Genomics & Sequencing Services with Antibody-Drug Conjugate (ADC)
8 published
8 published CROs match Genomics & Sequencing Services and Antibody-Drug Conjugate (ADC).
Locations in this set include United States, China, United Kingdom, Europe, Finland, and India.
Capabilities that show up most often in this set: Biomarker Assays, Flow Cytometry Services, In Vitro Pharmacology, In Vivo Efficacy Models, and Preclinical In Vitro Studies.
Matching companies
Axcelead Drug Discovery Partners, Inc.Axcelead provides integrated drug discovery research services to pharmaceutical companies, biotech ventures, and academic institutions. Founded in 2017 from Takeda's drug discovery research base, the company offers expertise across small molecules, nucleic acids, antibodies, and multiple therapeutic modalities.
Champions OncologyLeading oncology CRO specializing in preclinical and clinical specialty testing, with over 1,400 patient-derived xenograft models, comprehensive multi-omic datasets, and proprietary platforms including flow cytometry, NGS, proteomics, and histopathology services.
Crown BiosciencePreclinical oncology CRO offering 2,500+ PDX models, organoid and cell line databases, and translational platforms with biomarker discovery and AI-driven systems biology for drug development.
Frontage LaboratoriesGlobal pharmaceutical development organization offering integrated drug discovery, preclinical safety/toxicology, DMPK, bioanalytical, and clinical trial services across 28 sites with 2,200 employees and 200+ FDA inspections.
LIDE BiotechOncology-focused preclinical CRO with AAALAC-accredited China-based labs offering 2300+ PDX models, MiniPDX organoid assays, and multi-omics analysis for drug discovery and development.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
Synexa Life SciencesBiomarker and bioanalytical CRO offering custom assay development, validation and clinical sample analysis by LC-MS/MS, MSD, flow cytometry and Olink proteomics. Labs in Manchester, Turku and Cape Town support work from discovery through regulatory submission.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Markdown mirror: /explore/genomics-services/antibody-drug-conjugate.md